Francine Foss, MD
A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodies. We also discuss the critical role of clinical trials in shaping the future of CTCL care.
DOWNLOAD TRANSCRIPT
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
Cutaneous T-cell Lymphoma Fact SheetRecent LLS T-cell lymphoma webcastLLS Clinical Trial Support CenterClinicalTrials.govStem cell transplantationCAR T-cell therapyBispecific antibodies – Immunotherapy fact sheetAdditional LLS Support Resources:
Free Nutrition ConsultationsInformation Specialists Financial supportFree telephone/web patient programs Free booklets Young Adult ResourcesOnline chats Support groups Caregiver support Caregiver WorkbookAdvocacy and Public PolicySurvivorship WorkbookLLS Community Mental Health ResourcesSupported by Kyowa Kirin, Inc.
The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with Blood Cancer United Podcast.